Press release Read more about AP Alternative Assets, L.P. Informs Investors of Availability of Additional Information Regarding Athene
Press release Read more about Hybrigenics’ inhibitor of Ubiquitin-Specific Protease 7 (USP7) shows activity in preclinical models of Chronic Lymphocytic Leukemia (CLL)